✦ LIBER ✦

A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors

✍ Scribed by Nael M. Mostafa,Yi-Lin Chiu,Lee S. Rosen…

Book ID: 126342480
Publisher: Springer
Year: 2014
Tongue: English
Weight: 238 KB
Volume: 74
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2529-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 and pharmacokinetic study of con

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors

✍ Adam S. Levy; Paul A. Meyers; Leonard H. Wexler; Regina Jakacki; Anne Angiolillo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

429 POSTER Phase 1 study of food effects

429 POSTER Phase 1 study of food effects on pharmacokinetics of brivanib alaninate in patients with advanced or metastatic solid tumors

✍ H. Hurwitz; P. LoRusso; G.I. Shapiro; A. Wolanksi; J. Chemidlin; E. Masson; S. S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase I study to assess the pharmacokine

Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors

✍ Nianhang Chen, Sant P. Chawla… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 600 KB

Clinical and pharmacokinetic study evalu

Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors

✍ William C. Zamboni; Sanjay Goel; Tahir Iqbal; Robert A. Parise; Sandra Strychor; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 278 KB

Effect of food and a proton pump inhibit

Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors

✍ Max E. Scheulen; Kaku Saito; Ralf A. Hilger; Bastian Mende; Christopher Zergebel 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 371 KB

313 A 1/2phase study to evaluate the pha

313 A 1/2phase study to evaluate the pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of albuferon™ in the treatment experienced subjects with chronic hepatitis C

✍ V. Balan; M. Sulkowski; D. Nelson; G. Everson; T. Bambury; J. Recta; J. Zhong; H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB